We also found that USP28 and SREBP2 proteins are highly expressed in tissues from human LSCC patients compared to adenocarcinoma and that deletion of Srebp2 reduced tumour formation in a KRas/p53/LKB1 mutant mouse model of lung cancer. This evidence concerns the gene TP53 and lung cancer.